Maze Therapeutics (MAZE) Net Income (2024 - 2026)

Maze Therapeutics has reported Net Income for 3 years, with the latest figure at -$19.6 million in Q1 2026.

• Quarterly Net Income rose 40.23% year-over-year to -$19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$90.4 million (down 315.65% YoY) and the FY2025 annual result came in at -$103.6 million, down 345.53% from the prior year.
• Net Income retreated to -$19.6 million in Q1 2026 per MAZE's latest filing, from -$7.0 million in the prior quarter.
• Over five years, Net Income peaked at $139.1 million in Q2 2024 and troughed at -$39.6 million in Q4 2024.
• A 3-year average of -$8.5 million and a median of -$27.7 million in 2024 frame the typical range for Net Income.
• The widest YoY moves for Net Income: up 82.25% in 2025, down 124.22% in 2025.
• Over 3 years, Net Income stood at -$39.6 million in 2024, then soared by 82.25% to -$7.0 million in 2025, then slumped by 178.62% to -$19.6 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered -$19.6 million, -$7.0 million, and -$30.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.